Anatara Lifesciences Ltd has released a press release.
Clinical Trials Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Half Year Accounts
- Appendix 4C and Q2 FY22 Activities Report
- Change of Director's Interest Notice
- Notification regarding unquoted securities - ANR
- Application for quotation of securities - ANR
Later from Anatara Lifesciences
- Appendix 4C and Q3 FY22 Activities Report
- Anatara Lifesciences announces leadership change
- Clinical Trial and Operational Update
- Quarterly Appendix 4C Cash Flow Report
- Q4 FY22 Activities Report
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences